Baxter International Inc. (B1AX34)
B3 Stock Exchange · Brazil · prices in BRL · close of 26 Oct 2026
Key indicators
| Last close | BRL 70.02 |
|---|---|
| 52-week range | 40.97 – 73.27 |
| Return, 1 month / 3 months | +20.8% / +28.3% |
| Return, 1 year / 3 years | +12.7% / −10.0% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 51.9% |
| Worst drawdown (1 year) | -34.3% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Baxter International is a medical products company that supplies hospitals and clinics with intravenous solutions, infusion systems and sterile supplies used in patient care. It also provides renal care products, including dialysis machines and related treatments for people with kidney disease, and offers surgical and other hospital products. The company is based in the United States and serves healthcare providers and medical institutions in many countries around the world.
Baxter International Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code B1AX34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Baxter International Inc. (B1AX34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 70.02 on 26 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 621 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.7% and over the last three months it rose 28.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.7% | ||
| From 52-week high | -1.9% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.3% | ||
| 6-month return | 54.5% | ||
| 12-month return, skipping the last month | -6.7% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.3% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 65.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +10.1% |
|---|---|
| 1 month | +20.8% |
| 3 months | +28.3% |
| 6 months | +54.5% |
| 1 year | +12.7% |
| 3 years | −10.0% |
| 5 years | −66.5% |
Signals
| 50-day / 200-day average | 63.69 / 54.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | USD 0.0171 |
| 27 May 2026 | USD 0.0176 |
| 25 Feb 2026 | USD 0.0174 |
| 26 Nov 2025 | USD 0.0184 |
| 27 Aug 2025 | USD 0.3074 |
| 28 May 2025 | USD 0.3134 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.